Barcelona-based biotech innovator Algaktiv has launched Exometics G, a breakthrough biomimetic exosome technology derived entirely from microalgae—marking a major leap forward in ethical, high-performance skincare. Engineered for precision and potency, Exometics G delivers over 10 billion vesicles per milliliter, allowing beauty brands to boast more than 10 million exosomes per drop.
With a tightly controlled particle size of 150 nanometers, this active ensures optimal skin absorption and efficacy in renewal, elasticity, and anti-aging. 100% vegan, cruelty-free, and lab-grown using patented technology, Exometics G circumvents the ethical and regulatory hurdles of animal- or human-derived exosomes while offering a sustainable, scalable solution with unmatched consistency.
"Exometics G overcomes the limitations of traditional exosomes, providing a standardized, high-potency alternative," said Jordi Ayats, product director at Algaktiv.
Science-Backed Skin Renewal
Algaktiv Launches Exometics G Vegan Biomimetic Exosomes for the Skin
Trend Themes
1. Vegan Biomimetic Exosomes - This innovation offers a plant-based alternative to animal-derived exosomes, catering to ethical and sustainable beauty demands.
2. Precision Skincare Delivery - The use of precisely engineered vesicles in skincare allows for enhanced absorption and targeted results in skin renewal.
3. Scalable Lab-grown Actives - Lab-grown technologies pave the way for scalable production of high-consistency skincare actives, eliminating reliance on natural sources.
Industry Implications
1. Biotech Skincare - Biotech-driven skincare formulations leverage advanced biology to address consumer needs for effective and ethical beauty products.
2. Sustainable Beauty - Sustainability-focused beauty products are gaining traction as consumers increasingly demand eco-friendly and cruelty-free options.
3. Cosmetic Nanotechnology - The application of nanotechnology in cosmetics introduces precision active delivery systems that enhance product performance.